{"name": "Insulet",
 "permalink": "insulet",
 "crunchbase_url": "http://www.crunchbase.com/company/insulet",
 "homepage_url": "http://www.insulet.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "international@insulet.com",
 "phone_number": "781.457.5000",
 "description": "medical device company",
 "created_at": "Thu Mar 18 19:00:22 UTC 2010",
 "updated_at": "Thu Jun 09 14:23:31 UTC 2011",
 "overview": "\u003Cp\u003EInsulet Corporation, a medical device company, engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes primarily in the United States. The company offers OmniPod Insulin Management System (OmniPod System), an insulin infusion system that provides a pain-free automated cannula insertion. The OmniPod System consists of OmniPod disposable insulin infusion device and handheld wireless personal diabetes manager; and provides people with a diabetes management solution that offers lifestyle and other benefits. The company sells the OmniPod System directly to patients through referrals from healthcare professionals and through patient leads. \u003C/p\u003E\n\n\u003Cp\u003EInsulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       54],
      "assets/images/resized/0008/7577/87577v1-max-150x150.png"],
     [[250,
       90],
      "assets/images/resized/0008/7577/87577v1-max-250x250.png"],
     [[253,
       92],
      "assets/images/resized/0008/7577/87577v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 63000000.0,
    "price_currency_code": "USD",
    "term_code": "cash_and_stock",
    "source_url": "http://www.sugartest.com/press_insulet.php",
    "source_description": "Insulet Announces Acquisition of Neighborhood Diabetes",
    "acquired_year": 2011,
    "acquired_month": 6,
    "acquired_day": 2,
    "company":
     {"name": "Neighborhood Diabetes",
      "permalink": "neighborhood-diabetes",
      "image":
       {"available_sizes":
         [[[150,
            103],
           "assets/images/resized/0013/7977/137977v1-max-150x150.png"],
          [[150,
            103],
           "assets/images/resized/0013/7977/137977v1-max-250x250.png"],
          [[150,
            103],
           "assets/images/resized/0013/7977/137977v1-max-450x450.png"]],
        "attribution": null}}}],
 "offices":
  [{"description": "HQ",
    "address1": "9 Oak Park Drive",
    "address2": "",
    "zip_code": "01730",
    "city": "Bedford",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "has named Charles Liamos as chief operating office",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 11,
    "source_url": "http://www.masshightech.com/stories/2011/01/10/daily25-Insulet-appoints-Liamos-to-COO-post.html",
    "source_text": null,
    "source_description": "Insulet appoints Liamos to COO post",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Insulet",
      "permalink": "insulet"}},
   {"description": "signed an exclusive distribution agreement with GlaxoSmithKline Inc. in Canada",
    "stoned_year": 2011,
    "stoned_month": 3,
    "stoned_day": 2,
    "source_url": "http://www.masshightech.com/stories/2011/02/28/daily44-Insulet-signs-insulin-device-distribution-deal-with-GSK.html",
    "source_text": null,
    "source_description": "Insulet signs insulin device distribution deal with GSK",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Insulet",
      "permalink": "insulet"}},
   {"description": "purchased Woburn-based medical equipment distributor Neighborhood Diabetes Inc. in a cash and stock deal worth approximately $63 millio",
    "stoned_year": 2011,
    "stoned_month": 6,
    "stoned_day": 6,
    "source_url": "http://www.masshightech.com/stories/2011/06/06/daily1-Insulet-pays-63M-for-Woburns-Neighborhood-Diabetes.html",
    "source_text": null,
    "source_description": "Insulet pays $63M for Woburn's Neighborhood Diabetes",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Insulet",
      "permalink": "insulet"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        126],
       "assets/images/resized/0008/7580/87580v1-max-150x150.jpg"],
      [[250,
        210],
       "assets/images/resized/0008/7580/87580v1-max-250x250.jpg"],
      [[450,
        378],
       "assets/images/resized/0008/7580/87580v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}